{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:09:22Z","timestamp":1792091362885,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.numecd.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T07:54:30Z","timestamp":1520495670000},"page":"582-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis"],"prefix":"10.1016","volume":"28","author":[{"given":"R.","family":"Kaseda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-7492","authenticated-orcid":false,"given":"H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dikalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Ikizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-0205","authenticated-orcid":false,"given":"V.","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2A","key":"10.1016\/j.numecd.2018.02.020_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90157-9","article-title":"A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study","volume":"80","author":"Castelli","year":"1986","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.numecd.2018.02.020_bib3","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.numecd.2018.02.020_bib4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.numecd.2018.02.020_bib5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2215\/CJN.06560714","article-title":"Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis","volume":"10","author":"Kopecky","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.numecd.2018.02.020_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor-2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.numecd.2018.02.020_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0000605-200912150-00162","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease","volume":"151","author":"Baker","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.numecd.2018.02.020_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.numecd.2018.02.020_bib10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"issue":"21","key":"10.1016\/j.numecd.2018.02.020_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2018.02.020_bib12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ki.2011.228","article-title":"Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients","volume":"80","author":"Chan","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1681\/ASN.2011030287","article-title":"Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis","volume":"23","author":"Gamboa","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2018.02.020_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12882-015-0162-x","article-title":"Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis\u2013a randomized cross-over study","volume":"16","author":"Gamboa","year":"2015","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.numecd.2018.02.020_bib15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1172\/JCI86401","article-title":"Serum amyloid a impairs the antiinflammatory properties of HDL","volume":"126","author":"Han","year":"2016","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.numecd.2018.02.020_bib17","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1194\/jlr.P076463","article-title":"Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction","volume":"58","author":"Zimetti","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2018.02.020_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.06.005","article-title":"Effect of chronic kidney disease on macrophage cholesterol efflux","volume":"136","author":"Meier","year":"2015","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.numecd.2018.02.020_bib19","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/S0022-2275(20)39210-5","article-title":"Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters","volume":"36","author":"Klansek","year":"1995","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S1431927608080069","article-title":"Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester","volume":"14","author":"Jerome","year":"2008","journal-title":"Microsc Microanal"},{"issue":"17","key":"10.1016\/j.numecd.2018.02.020_bib21","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.105.538934","article-title":"Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice","volume":"112","author":"Dikalova","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ab.2006.03.010","article-title":"Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column","volume":"353","author":"de Jong","year":"2006","journal-title":"Anal Biochem"},{"issue":"9","key":"10.1016\/j.numecd.2018.02.020_bib23","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/art.39675","article-title":"Effect of drug therapy on net cholesterol efflux capacity of high-density lipoprotein-enriched serum in rheumatoid arthritis","volume":"68","author":"Ormseth","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.numecd.2018.02.020_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","article-title":"Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism","volume":"67","author":"Ronda","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.numecd.2018.02.020_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ndt\/gfi068","article-title":"Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment","volume":"21","author":"Vogt","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.numecd.2018.02.020_bib26","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.ki.5002491","article-title":"HDL-inflammatory index correlates with poor outcome in hemodialysis patients","volume":"72","author":"Kalantar-Zadeh","year":"2007","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.numecd.2018.02.020_bib27","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ndt\/gfu022","article-title":"Elevated high-density lipoprotein cholesterol\u00a0and cardiovascular mortality in maintenance hemodialysis patients","volume":"29","author":"Moradi","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.atherosclerosis.2011.10.038","article-title":"Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients","volume":"220","author":"Honda","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000104","article-title":"Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease","volume":"2","author":"Kennedy","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.numecd.2018.02.020_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2005.08.009","article-title":"Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"186","author":"Takaya","year":"2006","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.numecd.2018.02.020_bib31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.numecd.2018.02.020_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s40620-014-0070-3","article-title":"Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients","volume":"27","author":"Hung","year":"2014","journal-title":"J Nephrol"},{"key":"10.1016\/j.numecd.2018.02.020_bib33","article-title":"IL-1 inhibition improves and HDL functionality in patients with stages 3 to 5 chronic kidney disease","author":"Hung","year":"2017","journal-title":"ASN Kidney Week"},{"issue":"9299","key":"10.1016\/j.numecd.2018.02.020_bib34","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.numecd.2018.02.020_bib35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2215\/CJN.06671208","article-title":"Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease","volume":"4","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.numecd.2018.02.020_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1681\/ASN.2013111219","article-title":"Restoration of renal function does not correct impairment of uremic HDL properties","volume":"26","author":"Kopecky","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475318300905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475318300905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T16:51:33Z","timestamp":1660582293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475318300905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0939475318300905"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2018.02.020","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}